CorpusHuman Anatomy
Cells & TissuesCell process

Transcription and RNA processing

Also known as: RNA polymerase II, pre-mRNA, mRNA, splicing, spliceosome, promoter, 5′ cap, poly(A) tail

Synthesis of RNA from a DNA template by RNA polymerase, followed in eukaryotes by capping, splicing and polyadenylation of pre-mRNA in the nucleus before export to the cytoplasm.

The Eukaryotic Cell

Overview

Pol II elongation rate≈1–4 kb/min
Poly(A) tail≈200 nt
Protein-coding sequence of the genome≈1–2 %

Eukaryotes have three nuclear RNA polymerases: RNA polymerase I (28S, 18S and 5.8S rRNA, in the nucleolus), RNA polymerase II (pre-mRNA and most snRNAs and microRNAs) and RNA polymerase III (tRNA, 5S rRNA and other small RNAs). Pol II cannot find promoters alone: general transcription factors assemble at the core promoter — TFIID binds the TATA box (≈25–30 bp upstream of the start site) through its TATA-binding protein — and TFIIH unwinds the DNA and phosphorylates the C-terminal domain of Pol II to release it into elongation. Gene-specific activators and repressors bound to enhancers and silencers, often tens of kilobases away, communicate with the promoter through the Mediator complex and DNA looping.

The polymerase reads the template (antisense) strand 3′ → 5′ and builds RNA 5′ → 3′, so the transcript has the same sequence as the coding (sense) strand, with U in place of T. RNA polymerases need no primer and do not proofread.

Pre-mRNA is processed co-transcriptionally: (1) a 5′ 7-methylguanosine cap protects the RNA and is needed for export and translation initiation; (2) splicing by the spliceosome (snRNPs U1, U2, U4, U5, U6) removes introns (which begin with GU and end with AG) as lariats and joins exons; alternative splicing, which affects ≈95 % of multi-exon human genes, lets one gene encode several proteins; (3) cleavage downstream of an AAUAAA signal and addition of a poly(A) tail (≈200 adenines) stabilise the mRNA. The mature mRNA is exported through nuclear pores.

Parts & subdivisions

  1. Promoter
    Core sequence (TATA box, initiator) where the pre-initiation complex assembles.
  2. Enhancers and silencers
    Distant regulatory sequences bound by transcription factors.
  3. RNA polymerase II
    Synthesises pre-mRNA; inhibited by α-amanitin.
  4. 5′ cap
    7-methylguanosine linked 5′–5′; recognised by eIF4E.
  5. Spliceosome
    snRNPs + proteins that excise introns.
  6. Poly(A) tail
    Added by poly(A) polymerase; bound by poly(A)-binding protein.

Function

  • Copies genetic information into RNA.
  • Determines which genes are expressed, when and how much.
  • Generates protein diversity through alternative splicing.

Clinical significance

Transcription inhibitors

α-Amanitin (death-cap mushroom, Amanita phalloides) inhibits RNA polymerase II → fulminant hepatic failure. Rifampicin inhibits bacterial RNA polymerase. Actinomycin D intercalates into DNA and blocks transcription (used for Wilms tumour).

Splicing defects

Splice-site mutations cause some β-thalassaemias. In spinal muscular atrophy (SMN1 loss), nusinersen — an antisense oligonucleotide — corrects splicing of the back-up gene SMN2. Anti-Smith antibodies (SLE) and anti-U1-RNP antibodies (mixed connective tissue disease) target snRNPs.

Test yourself

Which RNA polymerase transcribes protein-coding genes and is inhibited by α-amanitin (death-cap mushroom)?
  1. RNA polymerase I
  2. RNA polymerase II
  3. RNA polymerase III
  4. Mitochondrial RNA polymerase

Answer: RNA polymerase II

Pol II makes pre-mRNA (and most snRNAs and miRNAs); Pol I makes 28S, 18S and 5.8S rRNA in the nucleolus; Pol III makes tRNA and 5S rRNA. α-Amanitin poisoning causes severe hepatotoxicity.

More cells & tissues questions

Compiled from standard anatomy and physiology references — see the Cells & Tissues sources. For education only; not medical advice.